Cargando…
New Highlights of Resveratrol: A Review of Properties against Ocular Diseases
Eye diseases are currently a major public health concern due to the growing number of cases resulting from both an aging of populations and exogenous factors linked to our lifestyles. Thus, many treatments including surgical pharmacological approaches have emerged, and special attention has been pai...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7865717/ https://www.ncbi.nlm.nih.gov/pubmed/33525499 http://dx.doi.org/10.3390/ijms22031295 |
_version_ | 1783647912200241152 |
---|---|
author | Delmas, Dominique Cornebise, Clarisse Courtaut, Flavie Xiao, Jianbo Aires, Virginie |
author_facet | Delmas, Dominique Cornebise, Clarisse Courtaut, Flavie Xiao, Jianbo Aires, Virginie |
author_sort | Delmas, Dominique |
collection | PubMed |
description | Eye diseases are currently a major public health concern due to the growing number of cases resulting from both an aging of populations and exogenous factors linked to our lifestyles. Thus, many treatments including surgical pharmacological approaches have emerged, and special attention has been paid to prevention, where diet plays a preponderant role. Recently, potential antioxidants such as resveratrol have received much attention as potential tools against various ocular diseases. In this review, we focus on the mechanisms of resveratrol against ocular diseases, in particular age-related macular degeneration, glaucoma, cataract, diabetic retinopathy, and vitreoretinopathy. We analyze, in relation to the different steps of each disease, the resveratrol properties at multiple levels, such as cellular and molecular signaling as well as physiological effects. We show and discuss the relationship to reactive oxygen species, the regulation of inflammatory process, and how resveratrol can prevent ocular diseases through a potential epigenetic action by the activation of sirtuin-1. Lastly, various new forms of resveratrol delivery are emerging at the same time as some clinical trials are raising more questions about the future of resveratrol as a potential tool for prevention or in therapeutic strategies against ocular diseases. More preclinical studies are required to provide further insights into RSV’s potential adjuvant activity. |
format | Online Article Text |
id | pubmed-7865717 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-78657172021-02-07 New Highlights of Resveratrol: A Review of Properties against Ocular Diseases Delmas, Dominique Cornebise, Clarisse Courtaut, Flavie Xiao, Jianbo Aires, Virginie Int J Mol Sci Review Eye diseases are currently a major public health concern due to the growing number of cases resulting from both an aging of populations and exogenous factors linked to our lifestyles. Thus, many treatments including surgical pharmacological approaches have emerged, and special attention has been paid to prevention, where diet plays a preponderant role. Recently, potential antioxidants such as resveratrol have received much attention as potential tools against various ocular diseases. In this review, we focus on the mechanisms of resveratrol against ocular diseases, in particular age-related macular degeneration, glaucoma, cataract, diabetic retinopathy, and vitreoretinopathy. We analyze, in relation to the different steps of each disease, the resveratrol properties at multiple levels, such as cellular and molecular signaling as well as physiological effects. We show and discuss the relationship to reactive oxygen species, the regulation of inflammatory process, and how resveratrol can prevent ocular diseases through a potential epigenetic action by the activation of sirtuin-1. Lastly, various new forms of resveratrol delivery are emerging at the same time as some clinical trials are raising more questions about the future of resveratrol as a potential tool for prevention or in therapeutic strategies against ocular diseases. More preclinical studies are required to provide further insights into RSV’s potential adjuvant activity. MDPI 2021-01-28 /pmc/articles/PMC7865717/ /pubmed/33525499 http://dx.doi.org/10.3390/ijms22031295 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Delmas, Dominique Cornebise, Clarisse Courtaut, Flavie Xiao, Jianbo Aires, Virginie New Highlights of Resveratrol: A Review of Properties against Ocular Diseases |
title | New Highlights of Resveratrol: A Review of Properties against Ocular Diseases |
title_full | New Highlights of Resveratrol: A Review of Properties against Ocular Diseases |
title_fullStr | New Highlights of Resveratrol: A Review of Properties against Ocular Diseases |
title_full_unstemmed | New Highlights of Resveratrol: A Review of Properties against Ocular Diseases |
title_short | New Highlights of Resveratrol: A Review of Properties against Ocular Diseases |
title_sort | new highlights of resveratrol: a review of properties against ocular diseases |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7865717/ https://www.ncbi.nlm.nih.gov/pubmed/33525499 http://dx.doi.org/10.3390/ijms22031295 |
work_keys_str_mv | AT delmasdominique newhighlightsofresveratrolareviewofpropertiesagainstoculardiseases AT cornebiseclarisse newhighlightsofresveratrolareviewofpropertiesagainstoculardiseases AT courtautflavie newhighlightsofresveratrolareviewofpropertiesagainstoculardiseases AT xiaojianbo newhighlightsofresveratrolareviewofpropertiesagainstoculardiseases AT airesvirginie newhighlightsofresveratrolareviewofpropertiesagainstoculardiseases |